When out-of-pocket costs rise for some neurology drugs, patients take less

When out-of-pocket costs rise for some neurology drugs, patients take less

What to read around the web today

• The next chapter for African genomics. Nature
• In a cramped Kendall Square, biotech startups sublet desks and squeeze into shared labs. STAT Plus
• ‘The spark has ignited.’ Latin American scientists intensify fight against sexual harassment. Science
• Rising out-of-pocket costs for dementia and neuropathy drugs lower patient adherence. STAT Plus
• Neuroscientist Phil Haydon sets sail to talk about epilepsy. The Scientist